Home > Boards > US OTC > Miscellaneous > Therapeutic Solutions International, Inc. (TSOI)

"Given the established safety profile of StemVacs™ from

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
x-ray-eyes Member Profile
 
Followed By 98
Posts 6,985
Boards Moderated 0
Alias Born 03/29/12
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 12:43:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 12:39:56 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/29/2020 6:08:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/28/2020 12:03:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2020 5:05:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2020 5:01:12 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 7/10/2020 10:26:14 AM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 7/9/2020 2:56:38 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/6/2020 5:16:05 PM
Therapeutic Solutions International Universal Donor Immunotherapy StemVacs™ Activates Antiviral Immune Cells InvestorsHub NewsWire - 6/30/2020 9:00:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 6/30/2020 6:23:08 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2020 2:42:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2020 2:36:40 PM
Therapeutic Solutions International Announces Intention to Use Clinical Stage NK Activating Cancer Immunotherapy InvestorsHub NewsWire - 6/22/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 1:17:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 1:14:11 PM
Therapeutic Solutions International Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway InvestorsHub NewsWire - 6/15/2020 7:06:21 AM
Therapeutic Solutions International Issues "NOT US" Notice to Shareholders InvestorsHub NewsWire - 6/14/2020 8:10:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 3:26:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 3:23:57 PM
Therapeutic Solutions International Reports QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer New InvestorsHub NewsWire - 6/11/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2020 1:46:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2020 1:29:30 PM
Therapeutic Solutions International Initiates 500 Volunteer COVID-19 Prevention Clinical Trial Using QuadraMune™ InvestorsHub NewsWire - 6/8/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2020 12:14:34 PM
x-ray-eyes   Tuesday, 06/30/20 10:40:28 AM
Re: x-ray-eyes post# 24441
Post # of 27410 
"Given the established safety profile of StemVacs™ from our previous studies, as well as the findings reported today, we are on track for advancing towards FDA interactions," said Dr. James Veltmeyer, Chief Medical Officer of the Company.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist